Aims and Scope of Advances in Therapy
Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals. The Managing Editor is Clare Shepherd. The journal publishes original clinical research papers and review articles. The journal was established in 1984 and published by Health Communications. Since 2008 it has been published by Springer Science+Business Media. Less
Key Metrics
CiteScore 

5
Eigenfactor 

0.005 - 0.01
H-Index 

74
Impact Factor 

< 5
Scite Index 

0.88 5-Year SI

SJR 

Q1Pharmacology (medical)

SNIP 

1.37
Recommended pre-submission checks
Powered by 

Topics Covered on Advances in Therapy
Advances in Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1984 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Advances in Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Advances in Therapy
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with HemophiliaA: Results from the PREDICT Study.
- 1 Jul 2026
- Advances in therapy
Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis.
- 1 Jul 2026
- Advances in therapy
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment Comparison.
- 1 Jul 2026
- Advances in therapy
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
- 1 Jul 2026
- Advances in therapy
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
- 1 Jul 2026
- Advances in therapy
Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes.
- 1 Jul 2026
- Advances in therapy
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with HemophiliaA: Results from the PREDICT Study.
- 1 Jul 2026
- Advances in therapy
Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis.
- 1 Jul 2026
- Advances in therapy
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment Comparison.
- 1 Jul 2026
- Advances in therapy
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
- 1 Jul 2026
- Advances in therapy
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
- 1 Jul 2026
- Advances in therapy
Comparative Effectiveness of Diroximel Fumarate vs. Dimethyl Fumarate in Persons with Multiple Sclerosis: A US Claims Analysis of Relapse Outcomes.
- 1 Jul 2026
- Advances in therapy